Pan-cancer Analysis Predicts PDCD4 as a Potential Diagnostic, Prognostic and Immune Infiltration-related Biomarker
(ندگان)پدیدآور
Haili JiangAnni XieTing WangWenjing ShiDie HuRui ShengChaozheng GaoTian Xie
نوع مدرک
Textزبان مدرک
Englishکلید واژگان
ImmunityBiomarker
Pan-cancer
PDCD4
Prognosis
شماره نشریه
3ناشر
Tehran, medical University Tehranسازمان پدید آورنده
Nanjing University of Chinese Medicine, Nanjing, China AND Department of Oncology Integrated Traditional Chinese and Western Medicine, The First Affiliated Hospital of Anhui Medical University, Hefei, Anhui, ChinaAnhui University of Chinese Medicine, Hefei, Anhui, China
Department of Oncology Integrated Traditional Chinese and Western Medicine, The First Affiliated Hospital of Anhui Medical University, Hefei, Anhui, China
Anhui Medical University, Hefei, Anhui, China
Anhui University of Chinese Medicine, Hefei, Anhui, China
Anhui University of Chinese Medicine, Hefei, Anhui, China
Anhui University of Chinese Medicine, Hefei, Anhui, China
Nanjing University of Chinese Medicine, Nanjing, China AND School of Pharmacy, Hangzhou Normal University, Hangzhou, China
شاپا
1735-15021735-5249



